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Abstract
Background: In the light of both the importance and large numbers of case series and cohort studies
(observational studies) in orthopaedic literature, it is remarkable that there is currently no validated measurement
tool to appraise their quality. A Delphi approach was used to develop a checklist for reporting quality,
methodological quality and generalizability of case series and cohorts in total hip and total knee arthroplasty with
a focus on aseptic loosening.
Methods: A web-based Delphi was conducted consisting of two internal rounds and three external rounds in
order to achieve expert consensus on items considered relevant for reporting quality, methodological quality and
generalizability.
Results: The internal rounds were used to construct a master list. The first external round was completed by 44
experts, 35 of them completed the second external round and 33 of them completed the third external round.
Consensus was reached on an 8-item reporting quality checklist, a 6-item methodological checklist and a 22-item
generalizability checklist.
Conclusions: Checklist for reporting quality, methodological quality and generalizability for case series and cohorts
in total hip and total knee arthroplasty were successfully created through this Delphi. These checklists should
improve the accuracy, completeness and quality of case series and cohorts regarding total hip and total knee
arthroplasty.
Keywords: Total Knee Arthroplasty, Total Hip Arthroplasty, Reporting Quality, Methodological Quality,
Generalizability
Background
Observational studies (case series and cohorts) provide
an important source of knowledge on total hip arthro-
plasty (THA) and total knee arthroplasty (TKA). In
addition to personal experience, they are the most com-
m o nt y p eo fe v i d e n c eu s e db yo r t h o p a e d i cs u r g e o n sf o r
clinical decision making according to a survey of the
participants at the 2007 Annual Meeting of the Ameri-
can Orthopaedic Association [1].
Nevertheless, their rank in the hierarchy of scientific
evidence is lower than evidence obtained from rando-
mised experiments, and they often suffer from lack of a
control group, incomplete data collection, selection bias
and confounding by indication [2]. Despite these issues,
case series and cohorts are important in signalling infer-
ior prosthesis designs, particularly those prone to aseptic
loosening, which accounts for 60% of THA revisions.
T h e ya r et h e r e f o r eav a l u a b l ea d d i t i o nt oc l i n i c a lt r i a l s
and implant registries [3-6]. Further advantages are great
detail, relatively low costs, short study completion time
and a potentially high external validity due to the inclu-
sion of a wide range of patients [2].
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case series and cohorts in orthopaedic literature as well
as the methodological issues mentioned above, it is
remarkable that there is currently no validated measure-
ment tool to appraise their quality [7]. A validated mea-
surement tool could contribute to more accurate,
transparent and complete case series and cohorts, result-
ing in higher quality [8]. Although STROBE is available
as a guideline for reporting in observational studies it
lacks details that are important for TKA and THA such
as details on type of implant and surgical technique.
Additionally, the STROBE-group has recently empha-
sized that STROBE is a reporting guideline and that it
should not be misused for the appraisal of methodologi-
cal quality [9].
The aim of this study was therefore to develop a tool to
appraise the reporting quality and methodological quality
of case series and cohorts of lower limb arthroplasty with
emphasis on revision for aseptic prosthesis loosening by
means of a Delphi approach. The second aim was to con-
struct a checklist of items that are important for the gener-
alizability of the results of case series and cohorts.
Methods
A Delphi approach was used for the development of a
checklist for reporting quality, a checklist for methodologi-
cal quality and a generalizability tool. The Delphi approach
is a well recognized research method for consensus forma-
tion amongst a group of experts through several iterations
of questionnaires [10,11]. The advantages are anonymity
of the participants, so avoiding dominance, expression of
consensus by summary measures and several iterations
with controlled feedback, which allows individuals to
change their opinion in light of the group’s response. A
Delphi takes full advantage of both the research and clini-
cal experience of the involved experts while imposing no
geographical limitations on participation [10].
Design of Delphi
An internet-based Delphi design was adapted from Gra-
ham et al. and the reporting was according to the CHER-
RIES guidelines for reporting results of internet E-
surveys [12,13]. The focus of the Delphi was on the revi-
sion rate for aseptic loosening in TKA and THA. During
the conceptual phase we determined that the checklists
should require quality items (internal validity) and gener-
alizability items (external validity) specific for TKA and
TKA. Furthermore the quality items should include
items for the appraisal of selection bias, confounding by
indication and competing events [2,14]. Additionally, the
c h e c k l i s t sh a dt ob ee a s yt ou s e ,b ea b l et ob ec o m p l e t e d
in an acceptable amount of time and had to allow for the
possibility that items be scored as “unknown” in cases
with insufficient information.
A master list of relevant items was created as a pre-
checklist to allow external experts to asses the face validity
and to further develop the final checklist through a Delphi
method in an efficient fashion with the desire to optimize
the construct validity. This kind of approach is common
for consensus development through a Delphi [15-17]. The
master list was generated from items of a recent systema-
tic review of the literature and from the Equator Network
website http://www.equator-network.org/ [18,19]. The
authors of the manuscript, the internal working group,
achieved consensus after evaluating and revising this mas-
ter list in two internal rounds. The actions of the internal
working group consisted of the rephrasing of selected
items, so that these items met the requirements described
above. Since item generation for the master list is an
important initial step that may determine the course of
the Delphi, we ensured that the members of the internal
working group covered all fields (TKA, THA and epide-
miology) of the Delphi, that no items were discarded dur-
ing the internal rounds and that the master list was as
comprehensive as possible. Additional aims of the internal
rounds were completion of the master list and further test-
ing and fine tuning of the web-based Delphi survey form.
During the external rounds of the Delphi survey the inter-
nal working group analyzed and discussed the external
experts’ answers after each round, modified the list of
items accordingly and rephrased, merged and clarified
individual items to optimize their clarity and conciseness.
T h eD e l p h is u r v e yc o n s i s t e do ft h r e ee x t e r n a lr o u n d s
and the external experts consulted were not involved in
the internal rounds and did not take part in the develop-
ment of the survey [16]. In accordance with the principles
of a Delphi survey each expert remained blind to the iden-
tity of other experts. The experts who completed the first
external round were invited to participate in the second
and third external rounds. During the second and third
round the experts received a newly created checklist
which was modified according to the results of the preced-
ing round. Each item of the newly created checklist was
presented with a summary of the groups’ response to
allow the experts change their answer in view of the
groups’ response [13].
Invited experts were identified via Pubmed and were
required to have had at least one international peer-
reviewed publication in the last three years in the field of
TKA, THA or evidence based medicine in more general
terms (expertise in musculoskeletal field or reporting
guidelines or advised by one of the authors). One remin-
der was sent to those experts who did not respond during
the first external round. Four reminders were sent to non
responders during the second and third external rounds.
The reminders consisted of a personal e-mail message
sent by the internal experts when applicable, in order to
maximize the response rate [20]. The first internal round
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concluded in June 2011.
Design and handling of the E-survey
An electronic form was created in Google documents
comprising 50 items in the first internal round, 42 items
in the second internal round, 45 items in the first exter-
nal round, 48 items in the second external round and
22 items in the third external round (only generalizabil-
ity). The survey consisted of general items (e.g. expert
name; remarks boxes), quality items and generalizability
items.
External experts were invited by e-mail to complete the
online survey. This e-mail contained a link to the survey,
information regarding the purpose of the Delphi and an
estimate of the duration of the survey as derived from the
internal rounds. Experts were informed that they would be
invited for further rounds before opening the survey. The
only incentive used was an offer to the external experts of
a mention in the acknowledgements on the condition of
completion of two rounds.
All items of the survey, except the remarks boxes, were
required items. Omitted questions were highlighted in
c a s e sw i t ha ni n c o m p l e t es u b m i s s i o n .T h es u r v e yc o n -
sisted of a mixture of multiple-choice and open questions
and included text boxes for remarks in order to take full
a d v a n t a g eo ft h ek n o w l e d g eo ft h ee x p e r tp a n e la n dt o
ensure creativity of the items. Furthermore all the multi-
ple-choice questions in the first external round had the
“other” option with a free text field, so that no restrictions
were placed on the answers of the experts. Additionally,
opportunity was given to the experts to add items, to mod-
ify wording of items and to give explanations and reasons
for their answers. Text boxes for remarks ensured that
experts could make additions, suggestions and remarks in
an unrestricted manner.
Each expert had to answer all questions. Since the sur-
vey comprised multiple areas of expertise the experts
could choose the option “no opinion“ when necessary.
Experts were able to view and change their answers
before submission.
Experts were also asked for their names and e-mail
addresses in order to prevent duplicate entries from the
same individual.
Domains of the Delphi
The three domains of the Delphi checklist were report-
ing quality, methodological quality and generalizibility.
Reporting quality and methodological quality
The Delphi distinguished between reporting quality and
methodological quality, because while reporting quality is
particularly important for transparency, methodological
quality is helpful in appraising and understanding the
sources and magnitude of bias in a study [9]. Accordingly,
a study with a high level of reporting quality may be meth-
odologically unsound (low methodological quality) and
vice versa.
Generalizability
The fact that two studies will never be completely identi-
cal poses difficulties for the comparability and generaliz-
ability of their results [21]. Since patient demographics,
component positioning, post operative functioning (activ-
ity level) and regional influences may all affect revision
rates for aseptic loosening, so it is important to investi-
gate to what extent each factor may differ between two
studies [5,22-24]. For example, are the results of a study
with 60% female patients comparable to those of a study
with 90% female patients when all other factors are the
same? Does each factor need to be exactly the same or
are small differences acceptable and if so, to what extend?
In order to identify relevant items, the experts were asked
to select items that are important for case series and
cohorts with aseptic loosening in TKA and THA. When
an item was chosen they were then asked to specify the
extent of the allowable difference, for each relevant fac-
tor, that would be acceptable when comparing different
studies in terms of generalizibility.
Statistical analysis
Standard descriptive statistics were used. For an item to
be included in the final checklists it must have been
selected by at least two thirds of the experts [25].
For generalizibility items the mode was determined,
which is the value that was chosen most frequently (e.g. 5
years). The preference for the mode value was calculated
by dividing the number of experts who chose the mode
value by the total number of experts who considered the
generilizability item relevant (NMode/NTotal ) The prefer-
ence was considered high in case 80% or more of the
experts chose the mode value. The preference was consid-
ered moderate in case 67% to 80% of the experts chose the
mode value and the preference was considered low in case
fewer than 67% of the experts chose the same value.
The “no opinion“ answers were not used for the calcu-
lation of agreement, because this option could be used
by experts when faced with a question outside the scope
of their expertise.
Results
Delphi flow
An overview of the Delphi flow and the number of
experts involved in each round is depicted in Figure 1. Of
the 272 experts contacted, 44 agreed to participate and
completed the first external round. 37 of them also com-
pleted the second (n = 35) or third (n = 33) external
round. These 37 external experts form the basis of this
Delphi and had a mean experience of 16 years (range 3
to 30 years; S D7.5), see Table 1 for the area of expertise.
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lows: 30 orthopaedic surgeons or residents, 5 epidemiolo-
gists, 1 biomedical engineer and 1 physical therapist. The
mean number of publications for all expert was 80 (range
2 to 445). The experts were of the following 17 national-
ities covering 5 continents: American, Argentinean, Aus-
t r a l i a n ,A u s t r i a n ,B e l g i a n ,B r i t i s h ,D a n i s h ,D u t c h ,F i n i s h ,
French, German, Indian, Israelian, Italian, Spanish, Swed-
ish and New Zealander. Additional characteristics of the
experts are presented in Table 1. The mean total comple-
tion time for all external rounds was 32 minutes SD 13
(range 17 to 65 minutes). There were no apparent differ-
ences in ratings and answers between the experts who
completed both external rounds and those who only par-
ticipated in the first external round.
Reporting quality and methodological quality
At the beginning of round 1 the Delphi consisted of two
domains as determined by the internal working group:
quality (internal validity) and generalizability (external
validity) After round 1 a clear distinction between
reporting items and methodological items was made, as
suggested by one of the external experts. The quality
items were therefore allocated to either the reporting
quality checklist or methodological quality checklist.
Furthermore, the FU-quotient has been added to metho-
dological quality item nr 3, as suggested by one of the
external experts [26]. Additional modifications after
round 1 consisted mainly of rephrasing. Some items
were divided into two separate items (5 years post-
operatively and 10 years post-operatively). Following
round 1 these items were compiled into one item with-
out a time specification. The responses of the experts to
reporting items and methodological items in all rounds
are presented in Additional File 1.
By the second external round, agreement was reached
on eight items relating to reporting quality as well as on
six items on methodological quality. Additionally, 21 of
the 35 experts indicated that a case series or cohort
should include at least 100 arthroplasties at baseline in
order to accurately determine the number of revisions
or revision rate. The answers ranged from a minimum
of 40 to a minimum of 300 arthroplasties. The final list
of items covering reporting quality and methodological
quality can be found in Table 2.
Generalizibility
After round 1 the following items were dropped from
the checklist, because less than two thirds of the exter-
nal experts found them relevant: Hospital for Special
Surgery Score (TKA), Merle D’Aubigné Score (THA)
and Range of Motion (THA). After the second round
the following items were added to the checklists, as sug-
gested by one of the experts: KOOS (TKA), WOMAC
(TKA), Oxford Knee Score (TKA), HOOS (THA),
WOMAC (THA) and Oxford Hip Score (THA). All
these six items were considered relevant in the third
round and thus remained in the final checklist.
Twenty-two items, related to the comparison of revi-
sion rates between studies, were agreed upon by the
Figure 1 Flowchart. Overview of the Delphi flow and the number
of experts involved in each round.
Table 1 Characteristics of the experts (n = 37) who
completed the external rounds
Count
Area of expertise
a
￿ Hip surgery 24
￿ Knee surgery 20
￿ Evidence Based Medicine 11
￿ Other
b 7
Background*
￿ Academic 27
￿ Public 9
￿ Private 6
￿ Other
c 2
a Multiple answers for each expert are possible. Therefore the total is more
than 37.
b One expert indicated “Implant Biology” in the other field. The remaining 6
answers in the other field were in addition to “Hip surgery”, “Knee surgery” or
“EBM”
c One expert indicated “Private Research Center” in the other field. The
remaining answer in the other field was in addition to “Private Hospital”.
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patient demographics, component positioning, post-
operative functioning and regional influences. The final
list of these generalizability items can be found in Table
3 and details about the procedure are available in Addi-
tional File 2.
Discussion
The AQUILA initiative resulted in a checklist for
reporting quality, methodological quality and generaliz-
ability for case series and cohorts of total hip and total
knee arthroplasty. The STROBE guidelines are already
available for use in reporting original patient research in
TKA and THA. The AQUILA checklist now adds to
these guidelines, as a treatment specific extension of
STROBE, addressing items that are specific for TKA
and THA in observational studies. Additionally, the
AQUILA checklist addresses both methodological qual-
ity and generalizability, while STROBE is strictly a
reporting guideline [9]. Since there are currently no spe-
cific checklists available for the assessment of case series
or descriptive cohorts in lower limb arthroplasty, nor in
orthopaedics in general, the AQUILA checklists should
have an important role in improving the accuracy, com-
pleteness and quality of TKA-and THA-related case ser-
ies and cohorts [8].
In terms of generalizability, there was consensus on
the items that are relevant when comparing revision
Table 2 The final AQUILA checklist for use by authors
Reportinbg Quality Item
1. Are the inclusion and exclusion criteria clearly reported?
2. Is information regarding the number of patients who did not gave informed consent and who were not willing to participate adequately
reported?
3. Are the baseline characteristics of included patients reported?
4. Is the surgical technique adequately reported?
5. Are the prosthesis brand and fixation reported with enough detail?
6. Are the reasons or definitions for revision adequately reported?
7. Are the number of revisions (N) and revision rates regarding aseptic loosening (either Kaplan-Meier or life table or revisions per 100 observed
component years) adequately reported?
8. Is the number of deaths, lost-to-follow up (e.g. no show at clinic or emigration), amputations, and revisions other than the primary endpoint
adequately reported?
Methodological Quality Item
1. Is there a clear primary research question/hypothesis?*
2. How were the cohorts constructed?
a. Consecutively
a
b. Non-consecutively
c. Unknown
3. How adequate was the follow-up (FU)?
a. Fully completed FU
b. 5% or less lost-to-FU or FU quotient
b is 1 or less
c. More than 5% lost-to-FU or FU quotient is more than 1
d. Unknown
4. How was the FU performed?
a. Predefined e.g. yearly
b. When patients had complaints or chart review (of non-predefined FU)
c. Unknown
5. How many arthroplasties are at risk at the FU of interest?
a. 20 or more
b. Less than 20
b. Unknown
6. Has a worst case analysis or competing risk analysis for competing endpoints [14] been performed?
* In cases of aseptic loosening: Does the research question or hypothesis include revision of the component due to aseptic loosening?
a Consecutively is defined as all patients receiving an arthroplasty (TKA or THA) in a defined period of time have also received the arthroplasty of interest. The
following situation is therefore non-consecutive: patients receiving prosthesis X while prosthesis Y has also been used for the same indication during the
specified period.
b FU quotient = Number lost to follow up/Number of failures [26].
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included postoperative functioning items only just
reached the cut off point of two thirds, see Additional
File 2. However, the preference for the mode values (e.g.
5 years) was mostly moderate and even low for some
items. This was most notable for component positioning
and some functional outcome scores and may be a
reflection of the ongoing research into the development
of a core set of outcome measures and the current con-
troversy in literature regarding neutral alignment of
prostheses [27,28].
We should also note some limitations. As mentioned
above, although consensus was achieved on the rele-
vance of the generalizability items, the preference for
t h em o d ev a l u e( e . g .5y e a r s )w a sm o s t l ym o d e r a t ea n d
even low for some items. The latter should therefore be
interpreted with some caution. Furthermore, the appli-
cation of a pre-checklist may have dampened the crea-
tivity of the external experts. However, this approach
has been successfully used in the development of other
checklists [15-17].
The possibility that the results were affected by non-
responder bias should also be considered. As is the case
for all surveys, the responders may have different opinions
to those of the non-responders. However, experts who
participate in a survey can be very similar to those
who decline, as demonstrated by a study from McKee
et al [29]. Indeed, the final expert panel in our study con-
sisted of a balanced sample representative of the interna-
tional musculoskeletal scientific community involving 17
nationalities on five different continents and included
experts with a wide range of experience (mean 16 years
Table 3 Final list of generalizability items
Generalizability item Mode
a NMode of NTotal (%)
b Preference for mode value
c
Patient demographics
Age 5 years 22 of 31 (71) M
Gender 10% 20 of 30 (67) M
Diagnosis 10% 17 of 31(55) L
BMI 5 points 16 of 29 (55) L
Component positioning
TKA Hip Knee Angle 5 degrees 13 of 24 (54) L
Varus/valgus tibial component 3 degrees 17 of 25 (68) M
Slope of tibial component 3 degrees 15 of 24 (63) L
THA Inclination of acetabular cup 10 degrees 19 of 28 (68) M
Varus/valgus femoral stem 5 degrees 16 of 27 (60) L
Post-operative functioning
TKA Knee Society Score 10 points 18 of 23 (78) M
Knee Society Function Score 10 points 20 of 24 (83) H
Range of Motion 10 degrees 18 of 24 (75) M
KOOS 10 points 11 of 17 (65) L
WOMAC Knee 10 points 11 of 19 (58) L
Oxford Knee Score 5 points 18 of 24 (82) H
THA Harris Hip Score 10 points 17 of 21 (81) H
HOOS 10 points 12 of 17 (71) M
WOMAC Hip 10 points 12 of 20 (60) M
Oxford Hip Score 5 points 16 of 22 (73) M
Regional influences
Are the studies from the same region (developing country or western countries//continents)?
Are the studies similar in type en experience of the surgeon (academic; high volume; consultant; trainee)?
Are two studies similar regarding hospital type (developer hospital/special institute/regular hospital)?
A Mode: the value that was chosen most frequently (e.g. 5 years)
b NMode = the number of experts who chose the mode value
NTotal = the total number of experts who considered the generalizability item relevant
c H = High preference, 80% or more of the experts chose the mode value
M = Moderate preference, between 67% and 80% of experts chose the mode value
L = Low preference, less than 67% of experts chose the mode value
Example: the preference for the mode value “5 years” is moderate.
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checklists was good and at least 88% of the experts with
an opinion consider the reporting quality and methodolo-
gical quality items relevant. Moreover, the experts were
unanimous in 8 out of 14 items.
The participation rate was 44/272 (16%). This is towards
the lower end of participation rates commonly achieved in
this type of survey [20,30]. The number of experts who
completed at least two external rounds (n = 37) is respect-
able, considering that some Delphi’sa r eb a s e do na sf e w
as 12 experts [11,13]. Our aim was to obtain a balanced
and representative sample of experts thus minimizing bias
due to the selection of a small group of experts with a par-
ticular opinion. This highly sensitive approach could
therefore have resulted in a dilution of available and inter-
ested experts. Accordingly, the response rate of the first
external round is the trade off for the representative and
balanced sample of experts obtained in our study. Further-
more, as only complete responses were recorded, incom-
plete responses could have been missed. Nevertheless 44
experts responded to the first external round and the
response rate in the second (80%) and third (75%) external
rounds was high.
I ti sn o tu n c o m m o nt h a ts t u d i e so ft h es a m et y p eo f
TKA or THA report rather different revision rates [31].
What factors have caused this difference? Are dissimilari-
ties in patient demographics the cause, or component
positioning, or post-operative functioning or perhaps
regional influences (including skill and experience of the
surgeon)? The generalizabity checklist provides a tool to
help address this issue. For example: if the difference in
mean age between two study populations is lager than 5
years, age is considered an important factor according to
the results of the AQUILA.
Although the name Assessment of Quality in Lower limb
Arthroplasty m a ys u g g e s to t h e r w i s e ,t h eA Q U I L Aw a s
developed specifically for THA and TKA, and does not
include Total Ankle Arthroplasty (TAA) or other types of
lower limb arthroplasty. However, some of the reporting
and methodological quality items may also be useful for
the appraisal of these types of lower limb arthroplasty stu-
dies, since the mechanisms of bias (e.g. selection bias and
competing risks) are the same [2,14]. On the other hand,
the recommended minimal number of arthroplasties at
baseline (100) may not be realistic for TAA Studies. Some
of the generalizibility items, especially regarding compo-
nent positioning and post-operative functioning may also
not be applicable to TAA studies.
While the AQUILA checklist was specifically devel-
oped for revision rates for aseptic loosening, it may also
be useful for other endpoints in lower limb arthroplasty,
such as revision rates for septic loosening or revision for
other reasons, since the mechanisms of bias are the
same [2,14].
Conclusions
In conclusion, the AQUILA checklist is the first tool
that can be used to assess the quality of reporting,
methodology and generalizibility in case series and
cohorts in lower limb arthroplasty. Use of the checklist
will lead to more accurate, transparent and complete
case series and cohorts in this field [8].
Additional material
Additional file 1: Experts’ responses to the AQUILA reporting
quality and methodological quality items.
Additional file 2: Experts’ responses to relevance of generalizability
items.
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